April 20, 2012
Nearly 20% of men with sexual dysfunction have impaired fasting glucose (IFG) and are more likely than men with normal glucose levels to have severe erectile dysfunction (ED), reduced penile blood flow, and overt hypogonadism as well as increased overall cardiovascular (CV) risk.
April 18, 2012
Testosterone supplementation is associated with improved exercise capacity in patients with moderate-to-severe heart failure.
March 07, 2012
Men receiving testosterone supplementation who also receive dutasteride, which blocks the conversion of testosterone to its potent metabolite 5α-dihydrotestosterone (DHT), do not experience a significant difference in changes in muscle-related measures or sexual function compared to men receiving testosterone without dutasteride.
November 02, 2011
Perrigo announced that it has submitted a New Drug Application (NDA) for testosterone gel 1% for the treatment of adult males who have low or no testosterone.
October 21, 2011
The FDA has approved Androderm (testosterone transdermal system; Watson) in 2mg and 4mg formulations.